Clinical Trials Market Size, Share, Future Trends, Growth Opportunities & Forecast 2032

The clinical trials market research covers key trends and forecasts from 2025-2032, with the global market projected to grow from $64.94 billion in 2025 to $104.41 billion by 2032, at a 6.8% CAGR.

Key findings include:

Market Segments:

• Phase III trials dominate with 55% market share, driven by large multicentre cohorts and regulatory requirements
• Oncology leads therapeutic areas with 27% revenue share
• North America holds 44.19% market share as of 2024

Major Growth Drivers:

• Rising chronic disease prevalence requiring new treatments
• Increasing outsourcing to Contract Research Organizations (CROs)
• Growing adoption of decentralized clinical trials
• Integration of AI for patient recruitment and data analysis

Key Challenges:

• Shortage of skilled clinical research coordinators
• High costs of biomarker-driven adaptive trial designs
• Patient recruitment and retention difficulties
• Complex regulatory compliance requirements

Leading Companies:

• IQVIA
• Laboratory Corporation of America Holdings
• ICON plc
• Parexel International
• Syneos Health

Recent developments include:

• Launch of "One Home for Sites" platform by IQVIA in June 2024
• Partnership between Thermofisher Scientific and National Cancer Institute for leukemia research
• Introduction of LabCorp Global Trial Connect service

Report-

Fortune Business Insights - Clinical Trials Market Size, Share, Trends | Growth Report [2032]

https://www.fortunebusinessinsights.com/clinical-trials-market-106930